Clinical Trial: The Effects of Continuous Use of Three Cosmetic Products on Skin with Mild Atopic Dermatitis Symptoms: single blinded study (Japan)

Tokyo, March 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061084) titled 'The Effects of Continuous Use of Three Cosmetic Products on Skin with Mild Atopic Dermatitis Symptoms' on March 27.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Open -but assessor(s) are blinded Control - No treatment

Primary Sponsor: Institute - Japan Clinical Trial Association

Condition: Condition - Healthy adult Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - Effects of continued use of the test articles on skin with mild atopic dermatitis symptoms Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - The test articles were used for 4 weeks on only one side of the face and one side of the arm (three articles on the face-soap, lotion, and serum-and only the serum on the arm) Interventions/Control_2 - Leave the other side of the face and the other side of the arm untreated

Eligibility: Age-lower limit - 20 years-old = Gender - Male and Female Key inclusion criteria - 1.Subjects diagnosed with atopic dermatitis or with a history of the condition 2.Subjects with a POEM score of 5-9 for the face and arms 3.Subjects whose symptoms have remained relatively stable over the past month and who have not started any new treatments or changed their current treatment regimen Key exclusion criteria - 1.Individuals with excessive exudate, or those with extensive severe inflammation, bleeding, or excoriations 2.Individuals who have regularly used topical steroids, topical immunomodulators, or tacrolimus ointment within the past 2 weeks; individuals who have used oral steroids or immunosuppressants within the past 4 weeks; or individuals who have used biologics within the past 6 months 3.Individuals with skin conditions other than contact dermatitis, psoriasis, or atopic dermatitis on the study sites 4.Individuals who have undergone cosmetic medical procedures on the study sites 5.Pregnant or breastfeeding women, or women planning to become pregnant 6.Individuals undergoing hormone replacement therapy 7.Individuals with severe liver or kidney disease 8.Individuals who have undergone phototherapy within the past month 9.Individuals with an allergy to any component of the test product 10.Individuals who have participated in a human clinical trial within the past month, or who plan to do so during the study period Target Size - 8

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 02 Month 10 Day Date of IRB - 2026 Year 02 Month 26 Day Anticipated trial start date - 2026 Year 03 Month 27 Day Last follow-up date - 2026 Year 04 Month 24 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069888

Disclaimer: Curated by HT Syndication.